Benjamin Shaker - Oct 19, 2022 Form 4/A - Amendment Insider Report for agilon health, inc. (AGL)

Signature
/s/ Timothy Bensley, as Attorney-in-Fact
Stock symbol
AGL
Transactions as of
Oct 19, 2022
Transactions value $
-$1,008,308
Form type
4/A - Amendment
Date filed
10/21/2022, 08:52 PM
Date Of Original Report
Oct 21, 2022
Previous filing
Jul 22, 2022
Next filing
Nov 18, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGL Common Stock Sale -$388K -19.6K -42.43% $19.84 26.5K Oct 19, 2022 Direct F1, F2, F3, F4
transaction AGL Common Stock Sale -$18.6K -900 -3.39% $20.62 25.6K Oct 19, 2022 Direct F1, F3, F4, F5
transaction AGL Common Stock Sale -$571K -28K -50.84% $20.35 27.1K Oct 20, 2022 Direct F1, F3, F4, F6
transaction AGL Common Stock Sale -$31K -1.5K -5.53% $20.66 25.6K Oct 20, 2022 Direct F1, F3, F4, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.52 to $20.36, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F3 Includes restricted stock units.
F4 The total was decreased by 1,507 shares as reported in the Form 4 Amendment filed on September 29, 2022.
F5 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.52 to $20.75, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F6 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $19.64 to $20.63, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
F7 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $20.64 to $20.71, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Remarks:

This Form 4 Amendment includes a footnote reference which was inadvertently omitted in the form filed on October 21, 2022.